Dr. Konoplev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2005 - 2006
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 2003 - 2004
- University of Cincinnati Medical Center/College of MedicineResidency, Pathology-Anatomic and Clinical, 2001 - 2003
- St Petersburg Medical State AcademyClass of 1990
Certifications & Licensure
- NJ State Medical License 2023 - 2025
- NY State Medical License 2022 - 2025
- TX State Medical License 2007 - 2025
- MI State Medical License 2006 - 2013
- OH State Medical License 2000 - 2003
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.Rivera, D., Cui, W., Gao, J., Peker, D., Zhang, Q., Dewar, R., Qiu, L., Konoplev, S., Hu, Z., Sasaki, K., Hu, A., E, S., Liu, M., Fang, H., Wang, W., Tang, G., Apperle...> ;Modern Pathology. 2024 Feb 1
- Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.Hurrish, K., Su, Y., Patel, S., Ramage, C., Zhao, J., Temby, B., Carter, J., Edwards, H., Buck, S., Wiley, S., Hüttemann, M., Polin, L., Kushner, J., Dzinic, S., White...> ;Biochemical Pharmacology. 2024 Feb 1
- Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jenna L Carter, Holly Edwards, Steven A Buck, Sandra E Wiley, Maik Hüttemann, Lisa Polin, Juiwanna Kus...> ;Research Square. 2023 Apr 28
- Join now to see all
Journal Articles
- CD123 Expression Patterns and Selective Targeting with a CD123-Specific Antibody-Drug Conjugate (IMGN632) in Acute Lymphoblastic LeukemiaL Jeffrey Medeiros, Hagop M Kantarjian, Jeffrey L Jorgensen, Marina Konopleva, Elias J Jabbour, Joseph D Khoury, Sa A Wang, Sergej N Konoplev, Haematologica
- High-Grade B-cell Lymphomas with TdT Expression: A Diagnostic and Classification DilemmaChi Young Ok, L Jeffrey Medeiros, Sergej Konoplev, Nitin Jain, Elias Jabbour, Guilin Tang, Nature
- An Inhibitor of Oxidative Phosphorylation Exploits Cancer VulnerabilityMarina Konopleva, Sergej Konoplev, Nature
Press Mentions
- MDS/CMML with KMT2A Rearrangements ‘Should Be Classified as AML’December 28th, 2021
- Cellectis Announces Two Oral Presentations and One Poster at the 2016 ASH Annual MeetingNovember 7th, 2016
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: